Please ensure Javascript is enabled for purposes of website accessibility

Why Teladoc Health Stock Rose More Than 7% on Wednesday

By Cory Renauer - Jun 22, 2022 at 12:04PM

Key Points

  • Shares of Teladoc Health rose more than 7% when the market opened today.
  • There isn't any relevant news responsible for the movement, so it appears to be floating higher along with the rest of the market.

Motley Fool Issues Rare “All In” Buy Alert

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

A market bouncing back from a very bad day on Tuesday is pulling Teladoc Health up as well.

What happened

Shares of Teladoc Health (TDOC 0.00%), a bellwether telehealth company, rose more than 7% this morning. The stock isn't moving in response to relevant news about the underlying business or the telehealth industry because there is none. The stock was still up 6.95% as of 11:18 a.m. ET on Wednesday.

So what 

Teladoc Health was a stock market darling that could do no wrong during the pandemic's early days. Now that most of us can see our doctors in person again, the demand for telehealth services has decelerated. When the company reported first-quarter results this April, management had to walk back the 2022 revenue guidance it had provided just three months earlier. Instead of a range of $2.55 billion to $2.65 billion, the company now expects total revenue to land in a range between $2.4 billion and $2.5 billion.

The midpoint of the revised revenue expectation represents a 20.5% year-over-year gain. That isn't bad, but it doesn't compare well to the whopping 86% gain reported in 2021.

Now what

Teladoc's market cap has fallen from over $36 billion at its peak down to just $5.4 billion at recent prices. That's a big drop, but we don't know if this stock has reached a bottom yet. 

The company's inability to execute on the $18.5 billion acquisition of Livongo led to a $6.6 billion write-down in the first quarter. Livongo's focus on chronic care was supposed to help Teladoc Health differentiate itself from a slew of competing telehealth services. While there's a chance it can turn its ship around, it's probably best to watch from the sidelines for now.

Invest Smarter with The Motley Fool

Join Over 1 Million Premium Members Receiving…

  • New Stock Picks Each Month
  • Detailed Analysis of Companies
  • Model Portfolios
  • Live Streaming During Market Hours
  • And Much More
Get Started Now

Stocks Mentioned

Teladoc Health, Inc. Stock Quote
Teladoc Health, Inc.
$38.81 (0.00%) $0.00

*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.

Related Articles

Motley Fool Returns

Motley Fool Stock Advisor

Market-beating stocks from our award-winning analyst team.

Stock Advisor Returns
S&P 500 Returns

Calculated by average return of all stock recommendations since inception of the Stock Advisor service in February of 2002. Returns as of 07/06/2022.

Discounted offers are only available to new members. Stock Advisor list price is $199 per year.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.